The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
β-Blockers for the Treatment of Misophonia and Misokinesia
Abstract
Misophonia is an adverse physical and emotional reaction to certain repetitive trigger sounds, usually generated by other people. Misokinesia refers to visual triggers that are sometimes (but not always) related to trigger sounds. Despite how common and disabling these conditions can be, medication treatment of misophonia and misokinesia is largely unexplored. We present the first case of using a β-blocker (propranolol) to successfully treat a patient experiencing misophonia and misokinesia. A moderate dose (60 mg) of propranolol completely eliminated multiple auditory and visual trigger symptoms related to other people eating. His trigger response symptoms included overwhelming negative emotions and prominent sympathetic overactivity (fight-or-flight response). These symptoms were so severe that he had avoided most meals with friends and family for the past several years. Propranolol eliminated the emotional and physiological effects of both the auditory and visual triggers, with an Amsterdam Misophonia Scale score reduction from 15 to 2. This enabled him to resume eating meals with family and friends with no distress. The medication was well tolerated. In summary, we report the novel finding that β-blockers were markedly effective at treating the physical and emotional symptoms of a patient with misophonia and misokinesia. This suggests a novel treatment approach for these conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is also a case study, conducted in 2022, wherein propranolol, a β-blocker, was used to successfully treat a patient experiencing misophonia and misokinesia by completely eliminating multiple auditory and visual triggering symptoms related to eating with other people [33].”
From Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field (2022) · cites this paper as [33]
In the citing paper
“Other drugs such as methylphenidate [90] and propranolol, a β-blocker [33], have also been used to attenuate misophonic symptoms.”
From Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field (2022) · cites this paper as [33]
Citations
Cites
Post-traumatic stress disorder: the neurobiological impact of psychological trauma
Sherin, J. E., & Nemeroff, C. B. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.2/jsherin · Cited by 750
Wilkinson, D. J. C., Thompson, J. M., Lambert, G. W., Jennings, G. L., Schwarz, R. G., Jefferys, D., Turner, A. G., & Esler, M. D. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.6.511 · Cited by 214
Misophonia Successfully Treated of with Fluoxetine: A Case Report
Sarigedik, E., & Yurteri, N. (2021) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000465 · Cited by 19
Zuschlag, Z. D., & Leventhal, K. C. (2021) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.20l02731 · Cited by 11
Cited by
Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field
Ferrer-Torres, A., & Giménez-Llort, L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116790 · Cited by 64
Williams, Z. J., Cascio, C. J., & Woynaroski, T. G. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.897901 · Cited by 68
How auditory processing influences the autistic profile: A review
Poulsen, R. E., Williams, Z. J., Dwyer, P. S. R., Pellicano, E., Sowman, P. F., & McAlpine, D. (2024) · Autism Research · doi:10.1002/aur.3259 · Cited by 48
A systematic review of treatments for misophonia
Mattson, S. A., D’Souza, J. M., Wojcik, K. D., Guzick, A. G., Goodman, W. K., & Storch, E. A. (2023) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2023.100104 · Cited by 47
A social cognition perspective on misophonia
Berger, J. I., Gander, P. E., & Kumar, S. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2023.0257 · Cited by 30
Metadata
- Authors
- Webb, J.
- Affiliations
- Yale University (US)
- Corresponding author
- Webb, Jadon
- Venue
- Clinical Neuropharmacology
- Published
- 2022-01
- Volume
- 45
- Issue
- 1
- Pages
- 13-14
- ISSN
- 0362-5664 (ISSN-L)
- 1537-162X
- OpenAlex
- W4205560768
- Cited by
- 18
- References
- 4
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 1 · 2022: 4
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Physical Sciences › Physics and Astronomy › Acoustics and Ultrasonics › Noise Effects and Management
- Health Sciences › Health Professions › Speech and Hearing › Hearing Loss and Rehabilitation
- Keywords
- misophonia, propranolol, beta-blockers, sympathetic hyperactivity, fight-or-flight response, social avoidance, pharmacotherapy
- MeSH terms
- Adrenergic beta-Antagonists, Hearing Disorders, Humans, Male, Phobic Disorders, Hyperacusis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: β-Blockers for the Treatment of Misophonia and Misokinesia. https://app.cochat.ai/papers/10.1097/wnf.0000000000000492
- The paper
- Webb, J. (2022). β-Blockers for the Treatment of Misophonia and Misokinesia. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000492
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.